Cargando…
Multiobjective optimization identifies cancer-selective combination therapies
Combinatorial therapies are required to treat patients with advanced cancers that have become resistant to monotherapies through rewiring of redundant pathways. Due to a massive number of potential drug combinations, there is a need for systematic approaches to identify safe and effective combinatio...
Autores principales: | Pulkkinen, Otto I., Gautam, Prson, Mustonen, Ville, Aittokallio, Tero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793282/ https://www.ncbi.nlm.nih.gov/pubmed/33370253 http://dx.doi.org/10.1371/journal.pcbi.1008538 |
Ejemplares similares
-
Systematic mapping of cancer cell target dependencies using high-throughput drug screening in triple-negative breast cancer
por: Wang, Tianduanyi, et al.
Publicado: (2020) -
Target-specific compound selectivity for multi-target drug discovery and repurposing
por: Wang, Tianduanyi, et al.
Publicado: (2022) -
Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
por: Gautam, Prson, et al.
Publicado: (2016) -
A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening
por: Gupta, Abhishekh, et al.
Publicado: (2020) -
Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects
por: Julkunen, Heli, et al.
Publicado: (2020)